Figure 2
From: Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection
Urinary biomarker levels. a) Comparison of urine concentrations of CCL-18 between the cancer and non-cancer groups (left panel), low-grade and high-grade (middle panel) and non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). b) Comparison of urine concentrations of A1AT between the same groups. Median levels are depicted by horizontal lines within boxes, standard deviations are depicted by bars. Significance (p < 0.05) was assessed by the Wilcoxon rank sum test.